May 2, 2016 Coalition Against Major Diseases (CAMD) Becomes a Partner in Massive Global Alzheimer’s Research Data-Sharing Network May 2, 2016 Coalition Against Major Diseases (CAMD) Becomes a Partner in Massive Global Alzheimer’s Research D
April 28, 2016 CDISC Announces Groundbreaking Clinical Trial Registry XML Standard April 28, 2016 CDISC Announces Groundbreaking Clinical Trial Registry XML Standard New CDISC CTR-XML standard enable
April 25, 2016 New Database for Sharing MS Clinical Trial Data April 25, 2016 Sharing Clinical Trial Data for Multiple Sclerosis Standardized and Pooled Data Available for Seconda
March 30, 2016 CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes March 30, 2016 CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology
February 23, 2016 Parkinson’s UK Announces Major Pharma Companies Sign Up to CPP Major pharma companies sign up to groundbreaking Parkinson’s consortium Seven of the world’s largest pharmaceutical companies
November 13, 2015 C-Path’s Polycystic Kidney Disease Outcomes Consortium Secures EMA Qualification Opinion for Enrichment Biomarker in ADPKD November 13, 2015 C-Path’s Polycystic Kidney Disease Outcomes Consortium Secures EMA Qualification Opinion for Enrichment Biomar
November 9, 2015 CDISC and C-Path Continue CFAST Partnership with Recently Awarded FDA Grants October 12, 2015 CDISC and C-Path Continue CFAST Partnership with Recently Awarded FDA Grants Austin, TX – 12 October 2015 – T
October 14, 2015 Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium October 14, 2015 Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium Data fro
August 30, 2015 Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrichment Biomarker in Autosomal Dominant Polycystic Kidney Disease (ADPKD) August 31, 2015 Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrich